Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	DHX36 MYO7A PEX6 PSMC6 SRCAP ARID1A HELB CCT8L2 MDN1 ACSBG1 MSH3 MSH5 MORC2 FIGN DICER1 IQCA1 MACF1 CCT8L1P KIF18B KIF13A	3.49e-05	614	232	20	GO:0140657
HumanPheno	Short philtrum	HIVEP2 SRCAP ARID1A GATAD2B HIRA UFD1 DENND5A MED12 FLII PIGL ADAMTS3 HUWE1 SIX3 NXN UNC80	9.08e-06	253	82	15	HP:0000322
Domain	MARK/par1	MARK1 MARK4 MARK2	7.02e-06	4	227	3	IPR033624
Domain	KA1	MARK1 MARK4 MARK2	1.74e-05	5	227	3	PF02149
Domain	KA1_dom	MARK1 MARK4 MARK2	1.74e-05	5	227	3	IPR001772
Domain	KA1	MARK1 MARK4 MARK2	1.74e-05	5	227	3	PS50032
Domain	-	MARK1 MARK4 MARK2	1.74e-05	5	227	3	3.30.310.80
Domain	UBA	MARK1 HUWE1 VPS13D MARK4 MARK2	2.82e-05	30	227	5	SM00165
Domain	KA1/Ssp2_C	MARK1 MARK4 MARK2	5.98e-05	7	227	3	IPR028375
Domain	UBA	MARK1 HUWE1 VPS13D MARK4 MARK2	7.04e-05	36	227	5	PF00627
Domain	ClpS	UBR1 UBR2	1.47e-04	2	227	2	PF02617
Domain	ClpS_core	UBR1 UBR2	1.47e-04	2	227	2	IPR003769
Domain	NLGN4	NLGN4X NLGN4Y	1.47e-04	2	227	2	IPR030025
Domain	UBA	MARK1 HUWE1 VPS13D MARK4 MARK2	1.87e-04	44	227	5	IPR015940
Domain	FERM_M	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	2.32e-04	46	227	5	PF00373
Domain	UBA	MARK1 HUWE1 VPS13D MARK4 MARK2	2.57e-04	47	227	5	PS50030
Domain	ARM-type_fold	STAG1 ARID1A LYST MROH2A RNPEPL1 RTTN HUWE1 FMNL3 ELMO3 PPP2R5B IPO9 PELP1 UNC45B	2.73e-04	339	227	13	IPR016024
Domain	-	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.13e-04	49	227	5	1.20.80.10
Domain	FERM_central	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.13e-04	49	227	5	IPR019748
Domain	FERM_domain	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.13e-04	49	227	5	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	IPR014352
Domain	FERM_1	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	PS00660
Domain	FERM_2	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	PS00661
Domain	FERM_3	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	PS50057
Domain	Band_41_domain	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	IPR019749
Domain	B41	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	3.44e-04	50	227	5	SM00295
Domain	Ribosomal_L7/12_C/ClpS-like	UBR1 UBR2	4.38e-04	3	227	2	IPR014719
Domain	-	UBR1 UBR2	4.38e-04	3	227	2	3.30.1390.10
Domain	ARM-like	STAG1 RIPOR3 ARID1A MED12 MROH2A RTTN HUWE1 ELMO3 IPO9 PELP1 UNC45B	4.86e-04	270	227	11	IPR011989
Domain	FERM_N	MYO7A EPB41L3 PTPN13 EPB41L5	6.59e-04	33	227	4	IPR018979
Domain	FERM_N	MYO7A EPB41L3 PTPN13 EPB41L5	6.59e-04	33	227	4	PF09379
Domain	AAA	PEX6 PSMC6 FIGN IQCA1	7.40e-04	34	227	4	PS00674
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NCOA6 PDE2A NDOR1 HIVEP2 MAN2B1 UBE4B MYO7A PEX6 SLC10A3 SRCAP ARID1A FHIP1B LYST KIAA2013 HIRA GGT7 MDN1 WIZ TMEM259 PLCG1 DENND5A CAMSAP1 CHPF MED12 IGSF3 DOC2A FLII SZT2 RNPEPL1 RTTN HUWE1 ZNF516 MARK4 TNK2 LTK	4.27e-14	1105	237	35	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD NCOA6 PLK2 HIVEP2 MAP4 GIGYF1 EPB41L3 ARHGEF17 LYST ERBIN PTPN13 MDN1 NFATC3 CGN NR3C2 CAMSAP1 WNK4 MAPKAP1 COBLL1 NCKIPSD EPB41L5 CRTC1 RAB11FIP1 E2F8 VPS13D IPO9 MARK4 MACF1 MARK2 KIF13A SH3RF3	4.88e-14	861	237	31	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CTTNBP2 MARK1 EPB41L3 GATAD2B KIAA2013 TRIM66 PARP4 CGN GRIN3A PLEKHH2 MED12 CSTF2T UACA COBLL1 EPB41L5 MORC2 DENND3 VPS13D IPO9 MACF1 UNC80	3.46e-11	493	237	21	15368895
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD PDE2A CTTNBP2 TSC1 EPB41L3 ERBIN EMSY GATAD2B HIRA MDN1 WIZ NFATC3 TMEM259 CAMSAP1 GOLGA2 GOLGA3 TBL1X CACNA1E FLII UACA HUWE1 TBL1XR1 P2RX7 PELP1 ZNF516 MACF1 TNR	6.35e-10	963	237	27	28671696
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	DHX36 NCOA6 STAG1 UBE4B SRCAP ARID1A ERBIN EMSY GATAD2B HIRA WIZ MED12 NFS1 INTS8 GREB1	1.57e-08	341	237	15	32971831
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MAP4 ETV6 PSMC6 FAM91A1 ERBIN EMSY GATAD2B STAT1 KIAA2013 HIRA PTPN13 MDN1 WIZ INTS2 MCAT MED12 CSTF2T MAPKAP1 UACA EPB41L5 CRTC1 RAB11FIP1 MORC2 TBL1XR1 INTS8 DICER1 APPL2 MACF1 EIF3B MARK2 STOM	4.05e-08	1497	237	31	31527615
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD NCOA6 TOX ERBIN DSCAML1 CLCN6 AKAP6 DICER1 SLIT1 MACF1 GRIP2 UNC80	5.52e-08	225	237	12	12168954
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SPTLC3 HIVEP2 UBE4B MAP4 PLCXD1 SDCCAG8 ARID1A ERBIN PTPN13 INTS2 PLCG1 DENND5A ALDH3B2 STX17 TBL1X UBR2 DPP6 UACA NLGN4Y APBB2 MSH5 HUWE1 TBL1XR1 NXN INTS8 LRRC27 MACF1 TNK2 GREB1 SH3RF3	1.24e-07	1489	237	30	28611215
Pubmed	Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane.	MYO7A CDH23 STRC STRCP1	1.44e-07	8	237	4	21165971
Pubmed	MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.	MARK1 MARK4 MARK2	3.12e-07	3	237	3	9108484
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MYO7A PSMC6 TSC1 NEB EPB41L3 MDN1 SEPTIN1 MED12 GOLGA2 WNK4 FLII MORC2 VPS13D WNT10A MARK2 SH3RF3	3.73e-07	497	237	16	36774506
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBR1 NCOA6 UBE4B MAP4 TATDN2 FAM91A1 ERBIN EMSY GATAD2B MDN1 CDT1 CSTF2T FLII UACA HUWE1 MORC2 URGCP ZNF516 EIF3B MARK2	4.29e-07	774	237	20	15302935
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SRCAP ARHGEF17 TRIM66 MDN1 AKAP6 UBR2 ADAMTS3 HUWE1	6.06e-07	104	237	8	9205841
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	MYO7A CDH23 STRC STRCP1	6.68e-07	11	237	4	31776257
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD PLCXD1 BACH2 PEX6 GIGYF1 SRCAP ACY1 EPB41L3 ARID1A GATAD2B TRIM66 WIZ PLD1 ADGRL2 KNL1 UACA KIAA1549 RAB11FIP1 DICER1 MARK4 MACF1 LTK KIF18B UNC80	7.98e-07	1116	237	24	31753913
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD PLK2 PDE2A HIVEP2 STAG1 UBE4B ARID1A DSCAML1 STAT1 TRIM66 PTPN13 WIZ PLCG1 SGSM3 CHPF GOLGA3 AKAP6 FLII PLA2G3 APBB2 NFKBID MSH3 HUWE1 INTS8 APPL2 MACF1	8.47e-07	1285	237	26	35914814
Pubmed	Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1.	ITGB2 PLCG1 RASGRP2	1.24e-06	4	237	3	14702343
Pubmed	Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells.	MAP4 MARK1 MARK2	1.24e-06	4	237	3	10542369
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RB1CC1 EPB41L3 PTPN13 WIZ MID1IP1 CAMSAP1 MED12 GOLGA3 CSTF2T KNL1 TBL1X CRTC1 HUWE1 ZNF516	1.28e-06	418	237	14	34709266
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD PRR5L MAP4 MARK1 FAM91A1 SRCAP ERBIN STAT1 PTPN13 INTS2 HPS1 PLCG1 PLD1 PLXNB1 AKAP6 POLD2 CRTC1 MSH5 HUWE1 E2F8 P2RX7 MACF1 KIF13A	1.72e-06	1084	237	23	11544199
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 UBR1 DHX36 UBE4B MAP4 PSMC6 TSC1 SRCAP EPB41L3 ARID1A ERBIN STAT1 HIRA MDN1 UFD1 PLCG1 MED12 FLII POLD2 EPB41L5 MSH3 HUWE1 IPO9 MACF1 EIF3B KIF18B	2.18e-06	1353	237	26	29467282
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	GIGYF1 ARID1A ERBIN PTPN13 UFD1 CAMSAP1 GOLGA2 EPB41L5 KIAA1549 MACF1 STOM	2.19e-06	263	237	11	34702444
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CYLD CTTNBP2 MARK1 GIGYF1 EPB41L3 ARID1A PTPN13 NYNRIN CGN NCKIPSD KIAA1549 RAB11FIP1 MARK2 SH3RF3	2.72e-06	446	237	14	24255178
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	UBR1 DHX36 MAN2B1 PEX6 FAM91A1 GIGYF1 PARP4 DENND5A KYNU GOLGA2 PLXNB1 MAPKAP1 MORC2 DICER1 URGCP DENND3 MARK2	2.76e-06	650	237	17	38777146
Pubmed	An unusually powerful mode of low-frequency sound interference due to defective hair bundles of the auditory outer hair cells.	CDH23 STRC STRCP1	3.09e-06	5	237	3	24920589
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX36 NCOA6 INTS2 ACSBG1 ADGRL2 PLXNB1 IGSF3 AKAP6 SZT2 KIAA1549 CRTC1 DICER1 URGCP FMNL3 ZNF516	4.11e-06	529	237	15	14621295
Pubmed	UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.	UBR1 UBE4B UFD1 UBR2 HUWE1 KLHL22	4.20e-06	62	237	6	18775313
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	FAM91A1 RB1CC1 FHIP1B WIZ AP3M2 DENND5A APBB2 MSH3 RAB11FIP1 TNK2 MARK2	4.72e-06	285	237	11	34369648
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NCOA6 NEB ARHGEF17 MDN1 FAM186A CAMSAP1 COBLL1 PELP1 MACF1 KIF13A	5.27e-06	234	237	10	36243803
Pubmed	Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.	MARK1 MARK4 MARK2	6.16e-06	6	237	3	23666762
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	MARK1 ERBIN PTPN13 ADGRL2 GOLGA3 MAPKAP1 UACA APBB2 EPB41L5 RAB11FIP1 APPL2 MACF1 MARK2	7.39e-06	421	237	13	36976175
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MARK1 ERBIN PTPN13 ACSBG1 CACNA1E FLII KIAA1549 APPL2 MARK4 MACF1 TNK2 MARK2 TNR	9.25e-06	430	237	13	32581705
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	EPB41L3 ERBIN PTPN13 STRA6 IGSF3 UACA EPB41L5 FMNL3 P2RX7 SPRY4 MARK2 STOM	1.23e-05	377	237	12	38117590
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CYLD ERBIN HELB PTPN13 CAMSAP1 GOLGA3 DICER1 VPS13D MACF1	1.47e-05	209	237	9	36779422
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	HIVEP2 PIDD1 NEB GATAD2B GGT7 PTPN13 CACNA1B IPO9 SLIT1 MACF1 MARK2	1.48e-05	322	237	11	26514267
Pubmed	Functional proteomics mapping of a human signaling pathway.	STARD13 NCOA6 MAN2B1 STAG1 PEX6 ERBIN GATAD2B CAMSAP1 CHPF KNL1 HUWE1 FMNL3 PELP1 MACF1 KIF13A	1.53e-05	591	237	15	15231748
Pubmed	Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions.	MAP4 MARK1 MARK2	1.71e-05	8	237	3	22298430
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	PRR5L MAP4 EPB41L3 ERBIN GATAD2B WIZ CSTF2T MAPKAP1 IPO9	1.84e-05	215	237	9	35973513
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	RB1CC1 EPB41L3 GATAD2B PLXNB1 MSH3 TBL1XR1 ZNF516	2.93e-05	128	237	7	23858473
Pubmed	The functional interactome landscape of the human histone deacetylase family.	STAG1 ETV6 EMSY GATAD2B MDN1 TBL1X HUWE1 TBL1XR1 DICER1 ZNF516	3.26e-05	289	237	10	23752268
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 HIVEP2 ARID1A EMSY HIRA WIZ MED12 TBL1X MSH3 TBL1XR1 ZNF516	3.27e-05	351	237	11	38297188
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAP4 FAM91A1 RB1CC1 EPB41L3 ERBIN STAT1 CGN ADGRL2 GOLGA2 GOLGA3 UACA COBLL1 MACF1 MARK2	3.82e-05	565	237	14	25468996
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD KCTD13 MAP4 MARK1 FAM91A1 PLPPR3 EPB41L3 ERBIN GATAD2B GGT7 ACSBG1 CAMSAP1 IGSF3 MAPKAP1 CACNA1B FLII HUWE1 NFS1 MACF1 EIF3B FAM131B	3.96e-05	1139	237	21	36417873
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	IGSF3 SZT2 VPS13D MACF1 TNR	4.05e-05	56	237	5	9455484
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	STARD13 PDE8A MYO7A SDCCAG8 CDH23 PSMC6 GIGYF1 PTPN13 CGN CHPF MAPKAP1 COBLL1 CRTC1 RAB11FIP1 NXN DICER1 URGCP IPO9 GYS1 MARK2 KIF18B SH3RF3 STOM	4.07e-05	1321	237	23	27173435
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TSC1 ERBIN NLGN4X CAMSAP1 PLXNB1 IGSF3 MAPKAP1 UACA EPB41L5 KIAA1549 RAB11FIP1 SPRY4 MARK2 STOM	4.12e-05	569	237	14	30639242
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CYLD MAP4 PSMC6 EPB41L3 HIRA PARP4 PTPN13 WIZ CAMSAP1 FLII UACA EPB41L5 MORC2 DICER1 MACF1 KIF18B	4.24e-05	724	237	16	36232890
Pubmed	The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.	CYLD TRAIP	4.62e-05	2	237	2	14676304
Pubmed	DPP10 modulates Kv4-mediated A-type potassium channels.	DPP6 DPP10	4.62e-05	2	237	2	15671030
Pubmed	Bound Waters Mediate Binding of Diverse Substrates to a Ubiquitin Ligase.	UBR1 UBR2	4.62e-05	2	237	2	28392261
Pubmed	Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.	CACNA1B CACNA1E	4.62e-05	2	237	2	15610184
Pubmed	The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.	NCOA6 GREB1	4.62e-05	2	237	2	31744881
Pubmed	Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway.	UBR1 UBR2	4.62e-05	2	237	2	20298436
Pubmed	mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization.	TSC1 CRTC1	4.62e-05	2	237	2	19052232
Pubmed	TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.	TBL1X TBL1XR1	4.62e-05	2	237	2	36206873
Pubmed	MARK2 phosphorylates KIF13A at a 14-3-3 binding site to polarize vesicular transport of transferrin receptor within dendrites.	MARK2 KIF13A	4.62e-05	2	237	2	38709923
Pubmed	Assignment of the gene for a ubiquitin fusion degradation protein (Ufd1l) to mouse chromosome 16B1-B4, syntenic with the Tuple1 gene.	HIRA UFD1	4.62e-05	2	237	2	9284932
Pubmed	Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome).	UBR1 UBR2	4.62e-05	2	237	2	16311597
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4X NLGN4Y	4.62e-05	2	237	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4X NLGN4Y	4.62e-05	2	237	2	24855039
Pubmed	Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.	SLFN5 STAT1	4.62e-05	2	237	2	28671669
Pubmed	Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytes.	PLD1 P2RX7	4.62e-05	2	237	2	17130901
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4X NLGN4Y	4.62e-05	2	237	2	37001827
Pubmed	Progressive hearing loss and increased susceptibility to noise-induced hearing loss in mice carrying a Cdh23 but not a Myo7a mutation.	MYO7A CDH23	4.62e-05	2	237	2	14648237
Pubmed	[Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits].	MYO7A CDH23	4.62e-05	2	237	2	18323324
Pubmed	Cdh23 mutations in the mouse are associated with retinal dysfunction but not retinal degeneration.	MYO7A CDH23	4.62e-05	2	237	2	14609561
Pubmed	MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway.	MARK4 MARK2	4.62e-05	2	237	2	35192892
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	4.62e-05	2	237	2	34910522
Pubmed	Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.	MARK1 MARK2	4.62e-05	2	237	2	16803889
Pubmed	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	TSC1 CRTC1	4.62e-05	2	237	2	22457330
Pubmed	Phospholipase D and mTORC1: nutrients are what bring them together.	PLD1 CRTC1	4.62e-05	2	237	2	22457329
Pubmed	Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons.	CHPF DICER1	4.62e-05	2	237	2	22952873
Pubmed	CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.	CYLD STAT1	4.62e-05	2	237	2	37549179
Pubmed	Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels.	DPP6 DPP10	4.62e-05	2	237	2	15911355
Pubmed	Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syndrome): severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation.	LYST HPS1	4.62e-05	2	237	2	15743322
Pubmed	Whole-Exome Sequencing in Familial Parkinson Disease.	TNK2 TNR	4.62e-05	2	237	2	26595808
Pubmed	Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex.	GOLGA2 GOLGA3	4.62e-05	2	237	2	8315394
Pubmed	Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1.	MYO7A CDH23	4.62e-05	2	237	2	20844544
Pubmed	c-Myb regulates cell cycle-dependent expression of Erbin: an implication for a novel function of Erbin.	ERBIN MYB	4.62e-05	2	237	2	22880131
Pubmed	Autophagy inhibition prevents lymphatic malformation progression to lymphangiosarcoma by decreasing osteopontin and Stat3 signaling.	TSC1 RB1CC1	4.62e-05	2	237	2	36813768
Pubmed	Enhanced diacylglycerol production by phospholipase D activation is responsible for abnormal increase in concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mice.	LYST PLD1	4.62e-05	2	237	2	24830864
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4X NLGN4Y	4.62e-05	2	237	2	18434543
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	4.62e-05	2	237	2	11687802
Pubmed	Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway.	UBR1 UBR2	4.62e-05	2	237	2	16606826
Pubmed	Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia.	UBR1 UBR2	4.62e-05	2	237	2	15548684
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4X NLGN4Y	4.62e-05	2	237	2	37080762
Pubmed	SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth.	TBL1X TBL1XR1	4.62e-05	2	237	2	27129164
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4X NLGN4Y	4.62e-05	2	237	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4X NLGN4Y	4.62e-05	2	237	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4X NLGN4Y	4.62e-05	2	237	2	24104404
Pubmed	Effects of ablation of N- and R-type Ca(2+) channels on pain transmission.	CACNA1B CACNA1E	4.62e-05	2	237	2	12074836
Pubmed	The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes.	PLD1 P2RX7	4.62e-05	2	237	2	14761980
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4X NLGN4Y	4.62e-05	2	237	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4X NLGN4Y	4.62e-05	2	237	2	22989184
Pubmed	Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch.	TSC1 CRTC1	4.62e-05	2	237	2	25213336
Pubmed	Stereocilia defects in waltzer (Cdh23), shaker1 (Myo7a) and double waltzer/shaker1 mutant mice.	MYO7A CDH23	4.62e-05	2	237	2	12121736
Pubmed	Structural basis of substrate recognition and specificity in the N-end rule pathway.	UBR1 UBR2	4.62e-05	2	237	2	20835242
Pubmed	Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells.	TSC1 RB1CC1	4.62e-05	2	237	2	32577608
Pubmed	Dipeptidyl peptidase (DP) 6 and DP10: novel brain proteins implicated in human health and disease.	DPP6 DPP10	4.62e-05	2	237	2	19676137
Pubmed	CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.	PLD1 P2RX7	4.62e-05	2	237	2	23793974
Interaction	YWHAG interactions	CYLD NCOA6 HIVEP2 KCTD13 MARK1 TSC1 GIGYF1 TNFRSF10A RB1CC1 EPB41L3 ARHGEF17 LYST ERBIN PTPN13 MDN1 NFATC3 CGN CAMSAP1 MAPKAP1 UACA COBLL1 NCKIPSD EPB41L5 CRTC1 HUWE1 RAB11FIP1 E2F8 VPS13D IPO9 MARK4 MACF1 TNK2 MARK2 KIF13A SH3RF3	7.45e-07	1248	230	35	int:YWHAG
Interaction	YWHAH interactions	CYLD NCOA6 HIVEP2 KCTD13 MARK1 TSC1 GIGYF1 RB1CC1 EPB41L3 ARHGEF17 LYST ERBIN PTPN13 NFATC3 CGN NR3C2 CAMSAP1 MAPKAP1 UACA COBLL1 NCKIPSD EPB41L5 CRTC1 HUWE1 RAB11FIP1 E2F8 VPS13D IPO9 MARK4 MACF1 MARK2 SH3RF3	1.13e-06	1102	230	32	int:YWHAH
Interaction	YWHAB interactions	CYLD KCTD13 MARK1 TSC1 GIGYF1 RB1CC1 NEB EPB41L3 ARHGEF17 ITGB2 LYST ERBIN PTPN13 NFATC3 CGN CAMSAP1 MAPKAP1 UACA COBLL1 NCKIPSD EPB41L5 CRTC1 RAB11FIP1 E2F8 VPS13D IPO9 MARK4 MACF1 MARK2 SH3RF3	1.73e-06	1014	230	30	int:YWHAB
Interaction	TOP3B interactions	NCOA6 PDE2A NDOR1 HIVEP2 MAN2B1 UBE4B MYO7A PEX6 SLC10A3 SRCAP ARID1A FHIP1B LYST KIAA2013 HIRA GGT7 MDN1 WIZ TMEM259 PLCG1 DENND5A CAMSAP1 CHPF MED12 IGSF3 DOC2A FLII SZT2 RNPEPL1 RTTN MSH3 HUWE1 PELP1 ZNF516 MARK4 TNK2 LTK	4.45e-06	1470	230	37	int:TOP3B
Interaction	YWHAQ interactions	CYLD NCOA6 HIVEP2 KCTD13 MAP4 MARK1 TSC1 GIGYF1 NEB EPB41L3 LYST ERBIN PTPN13 NFATC3 CGN CAMSAP1 WNK4 MAPKAP1 UACA COBLL1 NCKIPSD EPB41L5 CRTC1 TUT1 RAB11FIP1 E2F8 VPS13D IPO9 MACF1 MARK2	1.19e-05	1118	230	30	int:YWHAQ
Interaction	PPM1H interactions	STARD13 FAM91A1 TSC1 GIGYF1 STAT1 PTPN13 CGN MAPKAP1 SH3RF3	1.20e-05	123	230	9	int:PPM1H
Interaction	YWHAZ interactions	CYLD HIVEP2 KCTD13 MARK1 TSC1 GIGYF1 RB1CC1 NEB EPB41L3 ARID1A ITGB2 LYST ERBIN PTPN13 NFATC3 PTPRO CGN CAMSAP1 GOLGA3 MAPKAP1 UACA COBLL1 NCKIPSD CRTC1 HUWE1 RAB11FIP1 E2F8 VPS13D IPO9 MARK4 MACF1 TNK2 MARK2	1.77e-05	1319	230	33	int:YWHAZ
Interaction	LCK interactions	CYLD EPB41L3 ERBIN STAT1 PTPN13 PLCG1 GOLGA2 GOLGA3 CSTF2T FLII COBLL1 EPB41L5 KIAA1549 NFKBID RAB11FIP1 MACF1 MARK2	2.52e-05	463	230	17	int:LCK
Interaction	RHOH interactions	FAM91A1 TSC1 TNFRSF10A ERBIN PTPN13 MDN1 ADGRL2 IGSF3 MAPKAP1 UACA EPB41L5 KIAA1549 RAB11FIP1 VPS13D APPL2 SPRY4 MARK2 STOM	2.58e-05	512	230	18	int:RHOH
Interaction	KIF13B interactions	STARD13 GIGYF1 PTPN13 CGN STX17 MAPKAP1 CRTC1 MARK2 SH3RF3	3.77e-05	142	230	9	int:KIF13B
Interaction	CDC42 interactions	UBR1 MAP4 PSMC6 FAM91A1 TNFRSF10A RB1CC1 EPB41L3 ERBIN STAT1 PTPN13 MDN1 INTS2 CGN PLD1 ADGRL2 KYNU IGSF3 COBLL1 EPB41L5 KIAA1549 MSH3 HUWE1 RAB11FIP1 FMNL3 IPO9 SPRY4 MARK4 TNK2 LTK MARK2 SH3RF3 STOM	4.63e-05	1323	230	32	int:CDC42
Interaction	SFN interactions	CYLD NCOA6 MAP4 MARK1 GIGYF1 NEB ARHGEF17 LYST ERBIN PTPN13 NFATC3 CGN CAMSAP1 MAPKAP1 COBLL1 EPB41L5 RAB11FIP1 IPO9 MACF1 MARK2 KIF13A	4.77e-05	692	230	21	int:SFN
Interaction	ATG9A interactions	PDE2A CIB4 FAM91A1 TNFRSF10A RB1CC1 SRCAP FHIP1B WIZ UFD1 AP3M2 DENND5A APBB2 MSH3 RAB11FIP1 TNK2 MARK2	5.61e-05	445	230	16	int:ATG9A
Interaction	DLG4 interactions	CYLD PDE2A NDOR1 KCTD13 PLPPR3 TSC1 EPB41L3 ERBIN NLGN4X GRIN3A GOLGA2 NCKIPSD HUWE1 NFS1 MACF1 SH3RF3	6.23e-05	449	230	16	int:DLG4
Interaction	MTCL3 interactions	KCTD13 TSC1 HUWE1 PPP2R5B TNK2	7.78e-05	39	230	5	int:MTCL3
Interaction	CAV1 interactions	PDE2A EPB41L3 ERBIN PTPN13 UFD1 NR3C2 PLCG1 PLD1 ADGRL2 GOLGA2 GOLGA3 IGSF3 COBLL1 APBB2 EPB41L5 KIAA1549 RAB11FIP1 SPRY4 MACF1 MARK2 STOM	9.05e-05	724	230	21	int:CAV1
Interaction	INPP5E interactions	STARD13 GIGYF1 PTPN13 CGN MAPKAP1 SH3RF3	9.75e-05	65	230	6	int:INPP5E
Interaction	YWHAE interactions	CYLD HIVEP2 KCTD13 MARK1 TSC1 GIGYF1 RB1CC1 EPB41L3 LYST ERBIN PTPN13 CGN CAMSAP1 GOLGA3 MAPKAP1 UBR2 COBLL1 NCKIPSD CRTC1 HUWE1 RAB11FIP1 E2F8 KLHL22 SMAGP IPO9 APPL2 MARK4 MACF1 MARK2 SH3RF3	1.02e-04	1256	230	30	int:YWHAE
Interaction	SH3PXD2A interactions	STARD13 MARK1 GIGYF1 PTPN13 CGN MAPKAP1 MARK2 SH3RF3	1.13e-04	128	230	8	int:SH3PXD2A
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO7A EPB41L3 PTPN13 PLEKHH2 EPB41L5	4.44e-05	50	142	5	1293
GeneFamily	AAA ATPases	PEX6 PSMC6 MDN1 FIGN IQCA1	5.90e-05	53	142	5	413
GeneFamily	MutS homologs\|PWWP domain containing	MSH3 MSH5	6.03e-04	5	142	2	1026
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR1 UBR2	1.25e-03	7	142	2	785
GeneFamily	CD molecules\|DASH family	DPP6 DPP10	1.25e-03	7	142	2	1205
Coexpression	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	PDE8A LYST MCAT AKAP6 APBB2 VPS13D	7.77e-07	36	236	6	M13327
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CYLD MYO7A MARK1 BACH2 TATDN2 GIGYF1 RB1CC1 NEB LYST DSCAML1 MDN1 NLGN4X PTPRO CGN GRIN3A GOLGA3 IGSF3 AKAP6 CACNA1E DPP6 ADAMTS3 KIAA1549 SIX3 DICER1 TNK2 GRIP2 KIF13A	2.76e-06	1106	236	27	M39071
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	HIVEP2 CTTNBP2 ERBIN PTPN13 PTPRO DPP6 UACA APBB2 EPB41L5 MACF1 KIF13A	3.83e-06	212	236	11	M39221
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	KCTD13 GIGYF1 SRCAP HIRA MDN1 TMEM259 SGSM3 DENND5A SZT2 TNK2 GRIP2 EIF3B MARK2	1.33e-05	338	236	13	M17094
Coexpression	GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN	PDE8A FAM91A1 ERBIN MID1IP1 CLCN6 GNA15 STX17 NCKIPSD DICER1 P2RX7	1.40e-05	199	236	10	M8487
Coexpression	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	PDE8A BACH2 MID1IP1 NR3C2 SGSM3 ZNF880 RAB11FIP1 FMNL3 MACF1 RASGRP2	1.40e-05	199	236	10	M9238
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	PDE8A MAP4 ARHGEF17 HIRA PARP4 UFD1 IGSF3 UBR2 DICER1 PPP2R5B GYS1	4.48e-05	276	236	11	M3063
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	DHX36 STAG1 SDCCAG8 STAT1 STX17 CSTF2T VPS13D MACF1 MYB	4.66e-05	184	236	9	M9005
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 DSCAML1 TDRD6 PLEKHH2 ANKK1 CACNA1B MROH2A CCDC7 CNTN3 UNC80	1.55e-08	160	237	10	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 DSCAML1 TDRD6 PLEKHH2 ANKK1 CACNA1B MROH2A CCDC7 CNTN3 UNC80	1.55e-08	160	237	10	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	T_cells-Tph_and_Tfh\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	TOX MYO7A ETV6 LYST STAT1 PTPN13 GNA15 PLXNB1 RAB11FIP1	4.54e-07	176	237	9	56c055488e34605d32562571a2fee621b47c9441
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A MYO7A TMEM91 GARIN5B UACA MROH2A MSH5 SLIT1 MYB	4.54e-07	176	237	9	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A MYO7A TMEM91 GARIN5B UACA MROH2A MSH5 SLIT1 MYB	4.54e-07	176	237	9	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	ASPN RIPOR3 ARHGEF17 DSCAML1 GRIN3A APBB2 FIGN DENND3 VPS13D	6.30e-07	183	237	9	273db6a3b00a93ca852498471187b642b5368185
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	PDE8A ASPN RIPOR3 ARHGEF17 DSCAML1 APBB2 FIGN DENND3 RASGRP2	7.54e-07	187	237	9	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 SLFN5 APBB2 DENND3 FMNL3 SMAGP UNC45B SPRY4 NOSTRIN	8.61e-07	190	237	9	632d5dc11765053366d61f0a0c7916111cea4f50
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 TOX STAG1 PTPN13 NR3C2 DPP6 APBB2 EPB41L5 KIF13A	1.21e-06	198	237	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	NLGN4X PTPRO PLEKHH2 DPP6 SPRY4 CNTN3 TNK2 TNR UNC80	1.32e-06	200	237	9	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_C\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FBXO40 PRR5L MARK1 ASPN NR3C2 SGCA COBLL1 GRIP2	1.53e-06	151	237	8	3f2abaa42876ce7a71d934ff16abe0cab0991a05
ToppCell	facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCXD1 ALDH3B2 CAMSAP1 PLXNB1 COBLL1 NCKIPSD PELP1 MARK4	2.59e-06	162	237	8	497ae9f86a5e7946d0fde932b35719a382a6b691
ToppCell	facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCXD1 ALDH3B2 CAMSAP1 PLXNB1 COBLL1 NCKIPSD PELP1 MARK4	2.59e-06	162	237	8	7b2949eba2b4aea239d96ed82aafab13b07624eb
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SYNDIG1L PDE2A NEB CGN CACNA1E LRRC55 GRIP2 GREB1	3.11e-06	166	237	8	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDT1 PLCG1 KIAA1549 DENND3 E2F8 SLC22A18 LRRC27 MARK4	3.25e-06	167	237	8	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	EPB41L3 CGN C10orf67 APBB2 EPB41L5 RAB11FIP1 NXN DENND3	4.40e-06	174	237	8	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAG1 LYST ERBIN NR3C2 GOLGA3 AKAP6 COL15A1 MACF1	4.79e-06	176	237	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARK1 ASPN ARHGEF17 AKAP6 SGCA COBLL1 GRIP2 RASGRP2	5.42e-06	179	237	8	8da6863edc756540bb097cc7221c1408640d9bb4
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARK1 ASPN ARHGEF17 AKAP6 SGCA COBLL1 GRIP2 RASGRP2	5.42e-06	179	237	8	f39c13c99a07d009cc677e363ffe089089c64916
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLK2 PDE2A ADGRL2 NXN DENND3 MACF1 NOSTRIN SH3RF3	5.65e-06	180	237	8	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 CDT1 CACNA1E EFL1 NFKBID MSH5 LTK RASGRP2	5.88e-06	181	237	8	d90faa6115b408c9fbca61fc90ff951e070754ba
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 DSCAML1 PARP4 PLEKHH2 TBL1X ADAMTS3 FIGN IQCA1	6.13e-06	182	237	8	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 PTPRO PLEKHH2 DPP6 UACA APBB2 EPB41L5 NXN	6.64e-06	184	237	8	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L3 CGN C10orf67 APBB2 EPB41L5 RAB11FIP1 NXN DENND3	6.91e-06	185	237	8	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	droplet-Kidney-KIDNEY-1m-Endothelial-kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 R3HDML COL15A1 UNC45B SPRY4 NOSTRIN	7.77e-06	188	237	8	b651024d58ed1bcfe0d80b21755f8bf709eda81f
ToppCell	droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 R3HDML COL15A1 UNC45B SPRY4 NOSTRIN	7.77e-06	188	237	8	51c6796a9488c056a10d048082015342c2e037f9
ToppCell	facs-Trachea-nan-3m-Endothelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 UACA DENND3 SMAGP UNC45B SPRY4	8.07e-06	189	237	8	f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11
ToppCell	facs-Trachea-nan-3m-Endothelial-endothelial_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 UACA DENND3 SMAGP UNC45B SPRY4	8.07e-06	189	237	8	e3d65417997bdd3f9c312c0977dceb6eca061029
ToppCell	facs-Trachea-nan-3m-Endothelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 UACA DENND3 SMAGP UNC45B SPRY4	8.07e-06	189	237	8	5559af03d9d612bb8dcf825e45744a9f8332bac8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L3 CGN C10orf67 APBB2 EPB41L5 RAB11FIP1 NXN DENND3	8.39e-06	190	237	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACY1 GGT7 C2orf42 NCKIPSD EPB41L5 INTS8 TNR	8.86e-06	137	237	7	0c82f815c014d01213d23b466043d6e57186dceb
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO7A NFILZ DSCAML1 MID1IP1 CDT1 GJA10 PPP2R5B	8.86e-06	137	237	7	761cc0e2b4971e98f6d0691d4575b5cd208b602d
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLK2 PDE2A SLFN5 DENND3 SMAGP UNC45B SPRY4 NOSTRIN	9.06e-06	192	237	8	5012cc3ec0766f06af447463413422b484446c43
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDE8A STAG1 ETV6 EPB41L3 DENND5A HS3ST4 KYNU PIK3R5	9.41e-06	193	237	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 ADGRL2 APBB2 KIAA1549 SMAGP UNC45B GRIP2 NOSTRIN	9.41e-06	193	237	8	ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPB41L3 CGN C10orf67 APBB2 EPB41L5 RAB11FIP1 NXN DENND3	1.01e-05	195	237	8	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN2B1 CDH23 ETV6 GNA15 KYNU NFKBID P2RX7 PIK3R5	1.01e-05	195	237	8	62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLK2 PDE2A NXN DENND3 FMNL3 MACF1 NOSTRIN SH3RF3	1.01e-05	195	237	8	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 BACH2 VSIG1 SLFN5 AP3M2 PLCG1 RASGRP2	1.09e-05	197	237	8	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPB41L3 CGN C10orf67 APBB2 EPB41L5 RAB11FIP1 NXN DENND3	1.09e-05	197	237	8	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	mild-dn_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HIVEP2 SLFN5 STAT1 HELB DPP6 TSGA13 SIX3 MYB	1.09e-05	197	237	8	07a1f59c83b748825e0708cd1cc7b63a2cb856cc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLEKHH2 DPP6 DPP10 CNTN3 TNK2 KIF13A TNR UNC80	1.17e-05	199	237	8	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	BACH2 ARID1A STAT1 PTPN13 WIZ CDT1 DENND5A KIAA1549	1.17e-05	199	237	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T\|COVID-19_Mild / Disease, condition lineage and cell class	HIVEP2 SLFN5 LYST STAT1 PARP4 PLCG1 MACF1 MYB	1.17e-05	199	237	8	f307d4887b28cf60a591439e278fd668409cb104
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	CDH23 PTPN13 RILPL2 NXN IQCA1 ZNF516 FAM181A SH3RF3	1.22e-05	200	237	8	b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAN2B1 PDE8A SRCAP ITGB2 GNA15 KYNU RAB11FIP1 GYS1	1.22e-05	200	237	8	851c57187db8bc91a393655bca5f13e787a723d4
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 CACNA1B DPP10 C10orf67 CCDC7 CNTN3 UNC80	1.28e-05	145	237	7	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	IIH-CD4-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	CYLD SYNDIG1L SLFN5 MYCBPAP STAT1 CGN GRIN3A	1.47e-05	148	237	7	ec626a44cea83f2a0e5c27fc8182f96446d297ac
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A SLFN5 HS3ST4 CACNA1B CCDC7 SMAGP UNC45B	2.24e-05	158	237	7	78b48b110b777bcc4c07cd23388bee911c0231d6
ToppCell	PBMC-Severe-cDC_4\|Severe / Compartment, Disease Groups and Clusters	TATDN2 CDH23 TMEM91 C2orf42 PLEKHH2 ZNF880 MSH3	2.42e-05	160	237	7	4dac64e58d9366c399f3d830848ccb720d400be7
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLFN5 STRA6 UACA RAB11FIP1 SMAGP UNC45B NOSTRIN	2.63e-05	162	237	7	0bdb1e5ba33e162bec1acb28256c1405a7658ee5
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLFN5 STRA6 UACA RAB11FIP1 SMAGP UNC45B NOSTRIN	2.63e-05	162	237	7	5799a602ef8d83925907e8e34532428be7330228
ToppCell	facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB2 LYST TMEM91 CD101 NFKBID RAB11FIP1 PIK3R5	2.73e-05	163	237	7	abec4389cd88252449f110fe95416d67424b403a
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLFN5 UACA COBLL1 RAB11FIP1 SMAGP UNC45B NOSTRIN	2.84e-05	164	237	7	6a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLFN5 UACA COBLL1 RAB11FIP1 SMAGP UNC45B NOSTRIN	2.84e-05	164	237	7	ec68954fc09b6850273b5e59caa6b09d02151097
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO DPP6 KIAA1549 E2F8 ZNF516 TNK2 TNR	2.84e-05	164	237	7	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CYLD TOX ETV6 ITGB2 GNA15 RAB11FIP1 KIF18B	3.07e-05	166	237	7	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLFN5 UACA COBLL1 RAB11FIP1 SMAGP UNC45B NOSTRIN	3.07e-05	166	237	7	27af6c906cff1d40d134f0386db7708869691121
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DSCAML1 CACNA1B CACNA1E DPP10 SLIT1 GREB1 UNC80	3.19e-05	167	237	7	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	368C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SYNDIG1L WIZ MCAT COL15A1 COBLL1 ZNF880 SPRY4	3.71e-05	171	237	7	f3bf5805823d5733b58742172e7668725ce82931
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-CD45____T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX ITGB2 ACSBG1 SEPTIN1 GNA15 NFKBID FAM131B	3.85e-05	172	237	7	6fc3ba9d20bae9aafe99259a7d705a1741a9294a
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TOX NEB ITGB2 SEPTIN1 DOC2A TNK2 LTK	3.99e-05	173	237	7	42272af45547422ef85e35f4a4c7d269e9ed7a8a
ToppCell	droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAIP HIRA GNA15 KNL1 DPP6 E2F8 KIF18B	3.99e-05	173	237	7	2eb6e9fc3a3654f6f86fbd112e80a18814afd103
ToppCell	droplet-Fat-SCAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 PDE2A CDH23 SLFN5 UACA UNC45B SPRY4	3.99e-05	173	237	7	eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc
ToppCell	Immune_cells-pro-B\|World / Lineage and Cell class	PDE2A MYO7A BACH2 MROH2A MSH5 SLIT1 RASGRP2	4.14e-05	174	237	7	e173adbf5789dfa20f3cbc668efde5f0992ac219
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TOX NEB ACSBG1 SEPTIN1 GNA15 KNL1 VPS13D	4.14e-05	174	237	7	33386750842c47ad7e7286d0f26a556da1a2de02
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TOX NEB ITGB2 SEPTIN1 DOC2A TNK2 LTK	4.14e-05	174	237	7	5c69447261c5aa309a24882656da90655728d637
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TOX NEB ACSBG1 SEPTIN1 GNA15 KNL1 VPS13D	4.14e-05	174	237	7	9344d4e76d7d9429aea87d3c0b98246200d16014
ToppCell	facs-Heart-RV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR5L MARK1 ASPN ARHGEF17 SPRY4 NOSTRIN RASGRP2	4.30e-05	175	237	7	bfac175b79bb7d3d81074a2407c206a7647ee75d
ToppCell	facs-Heart-RV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR5L MARK1 ASPN ARHGEF17 SPRY4 NOSTRIN RASGRP2	4.30e-05	175	237	7	c94fb35bbac95123201ca87ca835aecaefc0c490
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	STARD13 TRAIP TRIM66 CDT1 CHRNA10 E2F8 KIF18B	4.45e-05	176	237	7	8813c01ea080f373fe3970c5e1ba4c2dca0f7f02
ToppCell	IIH-CD8-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	TSC1 STAT1 GGT7 CLCN6 RTTN NFS1 SLC22A18	4.62e-05	177	237	7	fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX NEB STAT1 GGT7 PTPN13 ACSBG1 P2RX7	4.79e-05	178	237	7	43eda32af2e5e28a92421612d0a4c21e5427a772
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	STARD13 MYO7A ETV6 PTPN13 RILPL2 WNT10A MYB	4.79e-05	178	237	7	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX NEB STAT1 GGT7 PTPN13 ACSBG1 P2RX7	4.79e-05	178	237	7	888add8935ef3aef9b6693c5698e9d1842e66337
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLK2 TNFRSF10A COL15A1 UACA DENND3 SMAGP NOSTRIN	5.14e-05	180	237	7	97e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARK1 ASPN ARHGEF17 COBLL1 SPRY4 GRIP2 RASGRP2	5.14e-05	180	237	7	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIPOR3 HIRA CDT1 RTTN E2F8 VPS13D KIF18B	5.32e-05	181	237	7	fe2f8b4bd8b09be8ba933529a16e1dca08740dab
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIPOR3 HIRA CDT1 RTTN E2F8 VPS13D KIF18B	5.32e-05	181	237	7	a16079b1c832456b974d9d06dd1a3eda63ac1bce
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	PDE8A RIPOR3 ARHGEF17 DSCAML1 PTPN13 APBB2 DENND3	5.32e-05	181	237	7	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	PDE8A RIPOR3 ARHGEF17 DSCAML1 PTPN13 APBB2 DENND3	5.51e-05	182	237	7	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 HIVEP2 ETV6 EPB41L3 HS3ST4 NXN SH3RF3	5.51e-05	182	237	7	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A SLFN5 COL15A1 UNC45B SPRY4 NOSTRIN	5.51e-05	182	237	7	f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A NYNRIN ADGRL2 FIGN HSPB9 UNC45B	5.70e-05	183	237	7	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 PTPRO DPP6 UACA APBB2 EPB41L5 NXN	5.70e-05	183	237	7	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBR1 ASPN ARHGEF17 PLXNB1 COBLL1 SPRY4 RASGRP2	5.70e-05	183	237	7	2f0dcc65ad4d90ef946919b4462280fdd20c5ea0
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 PDE2A NYNRIN ADGRL2 FIGN HSPB9 UNC45B	5.70e-05	183	237	7	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	PDE8A ASPN RIPOR3 ARHGEF17 DSCAML1 APBB2 DENND3	5.70e-05	183	237	7	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 PTPRO DPP6 UACA APBB2 EPB41L5 NXN	5.70e-05	183	237	7	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBR1 ASPN ARHGEF17 PLXNB1 COBLL1 SPRY4 RASGRP2	5.70e-05	183	237	7	0f02136359787bd78146617990968baa47a65d86
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTLC3 R3HDML ACSBG1 CGN SGSM3 ALDH3B2 SLC22A18	5.70e-05	183	237	7	7eaa6ef7c6cf848fd6489f97677f4406318da22f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLPPR3 ERBIN TMEM91 PTPRO GRIN3A IGSF3 RASGRP2	6.11e-05	185	237	7	739260f8abebaf10a5cc49d91726278579e26170
ToppCell	mild-unassigned\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBPAP PTPN13 SEPTIN1 CACNA1E EPB41L5 MARK4 STOM	6.32e-05	186	237	7	5b2e1a58916f392fa1156bf9210df528775248ff
ToppCell	facs-Heart-LA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBR1 ASPN ARHGEF17 ANKK1 COBLL1 SPRY4 RASGRP2	6.32e-05	186	237	7	e2ba9f3518d87a44537a57a648df17ab98fbbb39
ToppCell	facs-Heart-LA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBR1 ASPN ARHGEF17 ANKK1 COBLL1 SPRY4 RASGRP2	6.32e-05	186	237	7	fda3415222f688ef5cd8de4b0b79daa2493c585f
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A	CYLD UBE4B NEB ARID1A EMSY NR3C2 PLCG1 PLD1 GOLGA2 CSTF2T PLXNB1 COBLL1 KLHL22	1.32e-07	197	233	13	6663_DN
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	NDOR1 KCTD13 MYO7A BACH2 LYST STRA6 ALDH3B2 EPB41L5 HUWE1 DENND3 CCDC7	4.22e-06	189	233	11	4672_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	KCTD13 PIDD1 HIRA WIZ CLCN6 ADGRL2 EPB41L5 TUT1 KLHL22 ZNF516 MARK2	5.16e-06	193	233	11	3810_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	SRCAP NEB CLCN6 NFATC3 TMEM259 HPS1 SGSM3 STRA6 CAMSAP1 CRTC1 KLHL22	5.16e-06	193	233	11	5633_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	STARD13 CYLD HIVEP2 UBE4B EPB41L3 HIRA TRIM66 CSTF2T TBL1X UBR2 APBB2	5.43e-06	194	233	11	4662_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; HL60; HG-U133A	CYLD STAG1 MAP4 PIDD1 RB1CC1 HIRA WIZ CDT1 GOLGA2 FLII VPS13D	5.43e-06	194	233	11	1404_UP
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A	NDOR1 PIDD1 SRCAP STRA6 COBLL1 APBB2 DICER1 VPS13D PPP2R5B IQCA1 MARK4	5.70e-06	195	233	11	2833_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	CYLD TRAIP SRCAP NEB CHRNA10 GOLGA2 SZT2 APBB2 HUWE1 IPO9 IQCA1	5.98e-06	196	233	11	5253_UP
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; MCF7; HT_HG-U133A	PIDD1 NEB HIRA WIZ PLCG1 SGSM3 STRA6 DOC2A COBLL1 PPP2R5B KIF13A	5.98e-06	196	233	11	6889_UP
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MAP4 SRCAP ARHGEF17 HIRA WIZ CLCN6 GOLGA2 CSTF2T TBL1X DOC2A MARK2	5.98e-06	196	233	11	4416_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	PIDD1 ETV6 NFATC3 CD101 HPS1 CHRNA10 PIGL PLA2G3 CRTC1 DENND3 VPS13D	5.98e-06	196	233	11	6305_UP
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A	HIRA CLCN6 ACSBG1 CHRNA10 KYNU CRTC1 SIX3 URGCP KLHL22 PPP2R5B MARK4	6.28e-06	197	233	11	4066_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ELOA2 KCTD13 MAP4 SRCAP ARID1A CLCN6 CAMSAP1 CSTF2T CRTC1 KLHL22 MYB	6.28e-06	197	233	11	3399_DN
Drug	Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; MCF7; HT_HG-U133A	EMSY PRODH2 PTPRO TMEM259 NYNRIN PLD1 CAMSAP1 MED12 PIK3R5 MYB RASGRP2	6.28e-06	197	233	11	5496_UP
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A	SPTLC3 PEX6 EMSY HIRA PLCG1 IGSF3 TUT1 PPP2R5B IPO9 MARK4 TNK2	6.59e-06	198	233	11	5869_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAP4 PIDD1 SRCAP WIZ HPS1 SGSM3 MED12 NCKIPSD TUT1 GYS1 TNK2	6.59e-06	198	233	11	6812_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CYLD HIVEP2 TRAIP PIDD1 SRCAP WIZ HPS1 PLCG1 STRA6 APBB2 KIF13A	6.59e-06	198	233	11	3869_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MAP4 TRAIP PIDD1 SRCAP ARHGEF17 CLCN6 NFATC3 PLCG1 ELMO3 IPO9 MYB	6.92e-06	199	233	11	2803_DN
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A	MAP4 ETV6 LYST STAT1 TMEM259 HPS1 SGSM3 CAMSAP1 EFL1 PIGL NFS1	6.92e-06	199	233	11	2045_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; HL60; HT_HG-U133A	CYLD MAP4 NEB TRIM66 PLCG1 SGSM3 CAMSAP1 TBL1X FLII RNPEPL1 APBB2	7.25e-06	200	233	11	1871_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	HIVEP2 STAG1 ARID1A EMSY HIRA CSTF2T COBLL1 URGCP E2F8 SMAGP	1.29e-05	174	233	10	7105_DN
Drug	prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	KCTD13 PIDD1 EMSY HIRA HPS1 PLCG1 CSTF2T TBL1X COBLL1 STOM	2.01e-05	183	233	10	6547_UP
Drug	thiacloprid	LYST MCAT CHRNA10 MED12 TBL1X	2.35e-05	34	233	5	CID000115224
Drug	Ethacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A	CYLD UBE4B TRAIP PLCG1 STRA6 KYNU CRTC1 KLHL22 ZNF516 MARK4	2.42e-05	187	233	10	1565_UP
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A	CYLD PDE8A PIDD1 SRCAP EPB41L3 WIZ NFATC3 KYNU RAB11FIP1 URGCP	2.42e-05	187	233	10	2017_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A GNA15 CDT1 KYNU PLXNB1 CRTC1 E2F8 KLHL22 PPP2R5B FAM131B	2.53e-05	188	233	10	5958_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CYLD MAP4 TRAIP SRCAP TRIM66 TMEM259 AP3M2 SGSM3 PLXNB1 UBR2	2.90e-05	191	233	10	5351_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ELOA2 SRCAP ARHGEF17 CLCN6 NYNRIN CAMSAP1 APBB2 MSH3 DICER1 KLHL22	2.90e-05	191	233	10	3387_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	TRAIP WIZ TMEM259 PLD1 ALDH3B2 COBLL1 CRTC1 SIX3 MARK4 MYB	3.03e-05	192	233	10	6639_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ELOA2 ETV6 ARID1A ARHGEF17 CLCN6 GNA15 STRA6 PLA2G3 CRTC1 MARK4	3.17e-05	193	233	10	5629_DN
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A	MAP4 ASPN PEX6 PLPPR3 SRCAP NFATC3 HPS1 SGSM3 KLHL22 ELMO3	3.17e-05	193	233	10	2505_DN
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	MAP4 TRAIP NEB EMSY HIRA DOC2A PIGL TUT1 IPO9 KIF13A	3.17e-05	193	233	10	3181_DN
Drug	Perphenazine [58-39-9]; Up 200; 10uM; HL60; HG-U133A	STARD13 CYLD UBE4B MAP4 PIDD1 HIRA SGSM3 KYNU PIGL APBB2	3.17e-05	193	233	10	2040_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	CYLD KCTD13 PIDD1 SRCAP NFATC3 CAMSAP1 CRTC1 HUWE1 DICER1 RASGRP2	3.31e-05	194	233	10	3969_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ETV6 NEB WIZ TMEM259 HPS1 GNA15 MED12 PLA2G3 ZNF516 MACF1	3.31e-05	194	233	10	5641_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	KCTD13 ITGB2 WIZ TMEM259 CDT1 SGSM3 PLXNB1 CRTC1 DENND3 KLHL22	3.31e-05	194	233	10	4331_DN
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	STARD13 MAP4 SRCAP EMSY HIRA PLCG1 KYNU CSTF2T TBL1X RAB11FIP1	3.31e-05	194	233	10	7098_DN
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	ELOA2 TRAIP PEX6 SRCAP EPB41L3 CLCN6 SGSM3 CRTC1 IPO9 RASGRP2	3.31e-05	194	233	10	828_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CYLD MYO7A ASPN SRCAP EPB41L3 CLCN6 CAMSAP1 RNPEPL1 PPP2R5B ZNF516	3.46e-05	195	233	10	6065_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	SRCAP ACSBG1 TMEM259 CD101 PLD1 CAMSAP1 PLXNB1 SZT2 CCDC7 MARK4	3.46e-05	195	233	10	3642_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NDOR1 MAP4 SRCAP ARHGEF17 NYNRIN HPS1 PLD1 COBLL1 PLA2G3 MARK4	3.46e-05	195	233	10	4180_DN
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A	STARD13 MYO7A NEB ARID1A HPS1 SGSM3 COL15A1 APBB2 MARK2 RASGRP2	3.46e-05	195	233	10	3047_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A	PLK2 KCTD13 TRAIP NEB WIZ KYNU TBL1X CRTC1 P2RX7 MARK4	3.61e-05	196	233	10	2335_UP
Drug	Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A	HIVEP2 MAP4 NEB ARHGEF17 SGSM3 CSTF2T PLA2G3 MSH3 ELMO3 MARK4	3.61e-05	196	233	10	2851_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	MAP4 NEB WIZ CSTF2T DOC2A RNPEPL1 APBB2 VPS13D ELMO3 PPP2R5B	3.61e-05	196	233	10	3284_DN
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MAP4 MYO7A HIRA PLCG1 CSTF2T MAPKAP1 RNPEPL1 VPS13D PPP2R5B KIF13A	3.61e-05	196	233	10	2210_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	CYLD PIDD1 LYST HPS1 SGSM3 MED12 PLA2G3 TUT1 ELMO3 GYS1	3.61e-05	196	233	10	4965_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CYLD ELOA2 MYO7A PEX6 ARID1A ARHGEF17 AKAP6 APBB2 VPS13D IQCA1	3.61e-05	196	233	10	3517_UP
Drug	Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	HIVEP2 PIDD1 HIRA NR3C2 CHPF GOLGA2 MAPKAP1 EFL1 PIGL RNPEPL1	3.61e-05	196	233	10	6330_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MAN2B1 KCTD13 TRAIP STAT1 HIRA NFATC3 SGSM3 PIGL URGCP ELMO3	3.61e-05	196	233	10	7175_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A	FBXO40 EMSY WIZ HPS1 PLCG1 PLD1 COBLL1 TUT1 SIX3 TNK2	3.61e-05	196	233	10	6637_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CYLD MAP4 SRCAP NEB PLD1 STRA6 CSTF2T APBB2 DICER1 PIK3R5	3.61e-05	196	233	10	4419_DN
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A	SPTLC3 PIDD1 SRCAP ARHGEF17 CLCN6 DOC2A RNPEPL1 COBLL1 APBB2 PPP2R5B	3.61e-05	196	233	10	4723_DN
Drug	Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A	KCTD13 HIRA WIZ HPS1 SGSM3 TBL1X CRTC1 MSH3 URGCP KIF13A	3.77e-05	197	233	10	3176_DN
Drug	Tyloxapol [25301-02-4]; Up 200; 4uM; HL60; HT_HG-U133A	FBXO40 MAP4 MYO7A WIZ PLCG1 ALDH3B2 COBLL1 APBB2 HUWE1 SIX3	3.77e-05	197	233	10	3074_UP
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	STARD13 MAP4 TRAIP PIDD1 TRIM66 GOLGA2 TBL1X COBLL1 KLHL22 MARK2	3.77e-05	197	233	10	6218_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ELOA2 HIVEP2 NEB LYST PLCG1 ALDH3B2 PLXNB1 PIGL COBLL1 VPS13D	3.77e-05	197	233	10	5387_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; HL60; HT_HG-U133A	KCTD13 MAP4 ASPN STAT1 HIRA KYNU PIGL COBLL1 KLHL22 RASGRP2	3.77e-05	197	233	10	2513_DN
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A	CYLD PIDD1 ARID1A EMSY HIRA SGSM3 CAMSAP1 CSTF2T DICER1 DENND3	3.77e-05	197	233	10	6563_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	ELOA2 UBE4B PIDD1 LYST PLCG1 RNPEPL1 COBLL1 PPP2R5B MARK4 KIF13A	3.77e-05	197	233	10	4717_DN
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ARHGEF17 WIZ TMEM259 NYNRIN CAMSAP1 RNPEPL1 CRTC1 TUT1 MARK4 GREB1	3.77e-05	197	233	10	3582_DN
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; HL60; HT_HG-U133A	PDE8A MAP4 MYO7A COBLL1 APBB2 CRTC1 TUT1 TNK2 MYB RASGRP2	3.77e-05	197	233	10	2457_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A	TRAIP STAT1 CHPF MED12 ADAMTS3 APBB2 MORC2 VPS13D PPP2R5B STOM	3.77e-05	197	233	10	5851_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	CYLD PIDD1 ETV6 LYST WIZ CLCN6 GNA15 STRA6 NFS1 VPS13D	3.77e-05	197	233	10	6801_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TMEM259 SGSM3 STRA6 GOLGA2 RNPEPL1 COBLL1 KLHL22 ELMO3 PPP2R5B ZNF516	3.77e-05	197	233	10	3314_DN
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NFATC3 TMEM259 MED12 CSTF2T TUT1 VPS13D APPL2 GYS1 TNK2 MARK2	3.77e-05	197	233	10	4829_DN
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	CYLD FBXO40 WIZ PLCG1 STRA6 SZT2 HUWE1 DENND3 PPP2R5B RASGRP2	3.77e-05	197	233	10	3562_UP
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A	FBXO40 NDOR1 ASPN SRCAP WIZ STRA6 KYNU APBB2 ZNF516 TNK2	3.77e-05	197	233	10	6653_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	STARD13 HIVEP2 SRCAP ARHGEF17 WIZ PLCG1 PLXNB1 DOC2A CRTC1 MARK4	3.77e-05	197	233	10	3877_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A	TRAIP SRCAP EMSY SGSM3 PLD1 CHRNA10 STX17 KYNU RNPEPL1 VPS13D	3.77e-05	197	233	10	2479_DN
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; HL60; HT_HG-U133A	KCTD13 TRAIP NEB CHRNA10 CAMSAP1 CHPF PIGL COL15A1 CRTC1 PIK3R5	3.77e-05	197	233	10	2357_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; HL60; HT_HG-U133A	ELOA2 PDE8A KCTD13 CLCN6 SGSM3 CAMSAP1 CHPF GOLGA2 KLHL22 TNK2	3.94e-05	198	233	10	3088_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	KCTD13 UBE4B MAP4 SRCAP LYST HIRA AP3M2 PIGL TUT1 VPS13D	3.94e-05	198	233	10	6929_DN
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A	CYLD ELOA2 KCTD13 MAP4 SRCAP WIZ NFATC3 KYNU COBLL1 SIX3	3.94e-05	198	233	10	3128_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ARID1A ERBIN ALDH3B2 CAMSAP1 ADGRL2 CSTF2T NCKIPSD DICER1 E2F8 VPS13D	3.94e-05	198	233	10	1070_DN
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A	HIVEP2 KCTD13 PIDD1 EMSY HIRA PLCG1 SGSM3 CHRNA10 KYNU VPS13D	3.94e-05	198	233	10	5738_DN
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	CYLD KCTD13 MAP4 PIDD1 TRIM66 CLCN6 SGSM3 PLA2G3 TUT1 IQCA1	3.94e-05	198	233	10	6248_UP
Drug	5194442; Down 200; 20uM; MCF7; HT_HG-U133A	TRAIP STAT1 HIRA WIZ SZT2 RNPEPL1 PLA2G3 EPB41L5 VPS13D MARK2	3.94e-05	198	233	10	6599_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	SPTLC3 ITGB2 TRIM66 WIZ CD101 PLCG1 GOLGA2 TUT1 DENND3 KLHL22	3.94e-05	198	233	10	4550_DN
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; HL60; HT_HG-U133A	ELOA2 MAP4 ASPN TRAIP SGSM3 APBB2 CRTC1 KLHL22 VPS13D MARK4	3.94e-05	198	233	10	2580_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	STARD13 HIVEP2 TRAIP WIZ CSTF2T UBR2 PIGL TUT1 URGCP GREB1	3.94e-05	198	233	10	7169_DN
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A	KCTD13 MAP4 TRAIP HIRA HPS1 PLXNB1 PIGL APBB2 EPB41L5 NXN	3.94e-05	198	233	10	6239_DN
Drug	Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MAP4 PEX6 PIDD1 ETV6 ARHGEF17 WIZ PLXNB1 MARK4 TNK2 GREB1	4.11e-05	199	233	10	6771_UP
Drug	Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A	HIVEP2 KCTD13 MAP4 NEB NFATC3 TMEM259 HPS1 RNPEPL1 APBB2 MARK2	4.11e-05	199	233	10	5701_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A	HIVEP2 MYO7A NEB TRIM66 NFATC3 SZT2 APBB2 VPS13D PPP2R5B KIF13A	4.11e-05	199	233	10	1470_UP
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	TRAIP EMSY STAT1 HIRA CLCN6 STRA6 CSTF2T SZT2 CRTC1 PPP2R5B	4.11e-05	199	233	10	4390_DN
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CYLD ETV6 SRCAP TRIM66 WIZ APBB2 CRTC1 PPP2R5B GREB1 MARK2	4.11e-05	199	233	10	6802_UP
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	ASPN PIDD1 LYST GNA15 CDT1 PLCG1 MACF1 LTK MARK2 KIF13A	4.11e-05	199	233	10	5509_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	CYLD SPTLC3 MYO7A SRCAP WIZ NFATC3 CD101 SGSM3 APBB2 KLHL22	4.11e-05	199	233	10	4562_DN
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A	CYLD SPTLC3 BACH2 ARID1A KYNU RNPEPL1 NCKIPSD EPB41L5 DENND3 KLHL22	4.11e-05	199	233	10	5057_DN
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; PC3; HT_HG-U133A	CYLD PEX6 SRCAP ARHGEF17 HIRA PLCG1 SGSM3 SZT2 APBB2 VPS13D	4.11e-05	199	233	10	5769_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; HL60; HG-U133A	KCTD13 UBE4B MAP4 PIDD1 NFATC3 HPS1 RAB11FIP1 NFS1 EIF3B RASGRP2	4.11e-05	199	233	10	1753_DN
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SPTLC3 PIDD1 ARHGEF17 LYST CLCN6 PLCG1 SGSM3 COBLL1 APBB2 MARK4	4.29e-05	200	233	10	4701_DN
Drug	Azaguanine-8 [134-58-7]; Up 200; 26.2uM; MCF7; HT_HG-U133A	HIVEP2 MAP4 SRCAP PLCG1 CAMSAP1 PIGL TUT1 VPS13D IPO9 ZNF516	4.29e-05	200	233	10	7444_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TRAIP EMSY HIRA HPS1 KYNU CSTF2T PLXNB1 DOC2A EPB41L5 VPS13D	4.29e-05	200	233	10	6503_DN
Drug	fullerene C60	DHX36 NCOA6 KCTD13 MYO7A PEX6 SRCAP ACY1 PNMA5 TMEM259 HPS1 GNA15 CDT1 MCAT WNK4 GOLGA3 CSTF2T IGSF3 CACNA1E PCDHGA5 MSH5 RAB11FIP1 NXN DENND3 KLHL22 PPP2R5B UNC45B GYS1 LRRC27 SPRY4 EIF3B SH3RF3 RASGRP2	6.31e-05	1498	233	32	ctd:C069837
Drug	tribromoethanol	CDH23 LYST NR3C2 FLII	8.12e-05	23	233	4	CID000006400
Drug	scriptaid; Up 200; 10uM; PC3; HT_HG-U133A	PLK2 UBE4B LYST STAT1 ACSBG1 PLD1 APBB2 RAB11FIP1 DENND3	8.72e-05	176	233	9	6896_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CYLD LYST ACSBG1 RAB11FIP1 NXN DENND3 PPP2R5B MARK4 RASGRP2	9.92e-05	179	233	9	6951_UP
Drug	aristolactam AII	CACNA1B CACNA1E	1.04e-04	2	233	2	CID000148657
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK1 MARK4 MARK2	1.86e-06	4	230	3	DOID:0070356 (implicated_via_orthology)
Disease	testosterone measurement	STARD13 UBR1 NCOA6 PDE2A PDE8A STAG1 TRAIP SRCAP ARID1A FAM186A NYNRIN C2orf42 PLCG1 HS3ST4 ADGRL2 SPOCD1 MED12 KNL1 TBL1X DPP6 EFL1 ADAMTS3 COBLL1 SLC22A18 GYS1 MACF1 GREB1	2.66e-06	1275	230	27	EFO_0004908
Disease	Autism Spectrum Disorders	CTTNBP2 NLGN4X TBL1X DPP6 DPP10 UNC80	5.50e-05	85	230	6	C1510586
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	6.05e-05	2	230	2	DOID:0110471 (implicated_via_orthology)
Disease	age at menarche	KCTD13 RB1CC1 ARID1A DSCAML1 GGT7 TRIM66 ADGRL2 EFL1 CRTC1 MSH5 SIX3 SLIT1 GREB1 NOSTRIN UNC80	7.32e-05	594	230	15	EFO_0004703
Disease	colon cancer (is_implicated_in)	NCOA6 ARID1A PTPN13 PIK3R5	1.74e-04	36	230	4	DOID:219 (is_implicated_in)
Disease	sensory system disease (implicated_via_orthology)	TBL1X TBL1XR1	1.81e-04	3	230	2	DOID:0050155 (implicated_via_orthology)
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1B CACNA1E	1.81e-04	3	230	2	DOID:0111181 (implicated_via_orthology)
Disease	response to paliperidone, schizophrenia symptom severity measurement	TOX PTPN13 PLD1 CACNA1B DPP10 KIAA1549 NFS1 NXN	3.11e-04	216	230	8	EFO_0007925, EFO_0007927
Disease	migraine (implicated_via_orthology)	CACNA1B CACNA1E	3.59e-04	4	230	2	DOID:6364 (implicated_via_orthology)
Disease	muscle measurement	PLK2 NEB	3.59e-04	4	230	2	EFO_0004515
Disease	Usher syndrome, type 1A	MYO7A CDH23	5.96e-04	5	230	2	C2931205
Disease	Endometrioid carcinoma ovary	PLK2 TNK2	5.96e-04	5	230	2	C0346163
Disease	USHER SYNDROME, TYPE IB (disorder)	MYO7A CDH23	5.96e-04	5	230	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	MYO7A CDH23	5.96e-04	5	230	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	MYO7A CDH23	5.96e-04	5	230	2	C1848640
Disease	Usher syndrome type 1	MYO7A CDH23	5.96e-04	5	230	2	cv:C1568247
Disease	Primary microcephaly	KNL1 DPP6 RTTN	6.45e-04	22	230	3	C0431350
Disease	Intellectual Disability	HIVEP2 STAG1 SDCCAG8 PEX6 ACY1 STRA6 AKAP6 CACNA1B CACNA1E RTTN MACF1	8.27e-04	447	230	11	C3714756
Disease	neutropenia, response to metamizole, Drug-induced agranulocytosis	STARD13 PTPRO	8.89e-04	6	230	2	EFO_0010971, HP_0012235, MONDO_0001475
Disease	Usher Syndrome, Type I	MYO7A CDH23	8.89e-04	6	230	2	C1568247
Disease	neurodegenerative disease (implicated_via_orthology)	UBR1 MARK1 UFD1 UBR2 MARK4 MARK2	9.93e-04	145	230	6	DOID:1289 (implicated_via_orthology)
Disease	mean corpuscular hemoglobin concentration	NDOR1 PRR5L BACH2 ETV6 GIGYF1 NEB CLCN6 ACSBG1 GNA15 CDT1 PCDHGA5 RNPEPL1 COBLL1 RTTN TBL1XR1 INTS8 E2F8 MACF1 MYB	1.13e-03	1105	230	19	EFO_0004528
Disease	Adenoid Cystic Carcinoma	SRCAP ARID1A ERBIN MARK2 MYB	1.14e-03	100	230	5	C0010606
Disease	gait measurement	SPATA31E1 TRAIP SDCCAG8 IGSF3 AKAP6 CRTC1	1.18e-03	150	230	6	EFO_0007680
Disease	Hereditary retinal dystrophy	MYO7A CDH23	1.24e-03	7	230	2	C0154860
Disease	Usher syndrome	MYO7A CDH23	1.24e-03	7	230	2	cv:C0271097
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1B CACNA1E	1.24e-03	7	230	2	DOID:0050951 (implicated_via_orthology)
Disease	gastric adenocarcinoma (is_marker_for)	ARID1A STAT1 PTPN13	1.33e-03	28	230	3	DOID:3717 (is_marker_for)
Disease	selenium measurement	SDCCAG8 ADGRL2 KYNU	1.47e-03	29	230	3	EFO_0006331
Disease	Embryonal Rhabdomyosarcoma	ARID1A SLC22A18	1.64e-03	8	230	2	C0206656
Disease	pseudohypoaldosteronism (is_implicated_in)	NR3C2 WNK4	1.64e-03	8	230	2	DOID:4479 (is_implicated_in)
Disease	neuroimaging measurement, brain volume measurement	CTTNBP2 PDE8A KCTD13 SDCCAG8 DSCAML1 GATAD2B NOSTRIN KIF18B	1.91e-03	286	230	8	EFO_0004346, EFO_0006930
Disease	22q11 partial monosomy syndrome	HIRA UFD1	2.10e-03	9	230	2	C3266101
Disease	Liver carcinoma	CYLD TRAIP TSC1 ARID1A STAT1 PPP4R3C CDT1 COL15A1 MSH5 E2F8 KIF18B	2.24e-03	507	230	11	C2239176
Disease	lymphocyte measurement	BACH2 GIGYF1 NFATC3 TMEM259 CDT1	2.28e-03	117	230	5	EFO_0803546
Disease	diastolic blood pressure, alcohol drinking	SDCCAG8 KIAA2013 CLCN6 FIGN SLIT1	2.36e-03	118	230	5	EFO_0004329, EFO_0006336
Disease	lymphocyte count	PLK2 UBE4B BACH2 CDH23 RIPOR3 GIGYF1 ITGB2 LYST ACSBG1 NR3C2 KYNU GOLGA3 KNL1 RILPL2 PCDHGA5 COBLL1 NFS1 NXN DENND3 MARK4 NOSTRIN MYB	2.57e-03	1464	230	22	EFO_0004587
Disease	response to corticosteroid, age at assessment	PLK2 HIVEP2	2.61e-03	10	230	2	EFO_0008007, GO_0031960
Disease	Pseudohypoaldosteronism, Type I	NR3C2 WNK4	2.61e-03	10	230	2	C0268436
Disease	Asymmetric crying face association	HIRA UFD1	2.61e-03	10	230	2	C0431406
Disease	Pseudohypoaldosteronism	NR3C2 WNK4	2.61e-03	10	230	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	NR3C2 WNK4	2.61e-03	10	230	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	NR3C2 WNK4	2.61e-03	10	230	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	NR3C2 WNK4	2.61e-03	10	230	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	NR3C2 WNK4	2.61e-03	10	230	2	C1449842
Disease	22q11 Deletion Syndrome	HIRA UFD1	2.61e-03	10	230	2	C2936346
Disease	C-reactive protein measurement	NCOA6 KCTD13 UBE4B TRAIP ETV6 RIPOR3 GATAD2B NYNRIN AKAP6 UBR2 PIGL COBLL1 SIX3 TBL1XR1 LRRC55 IPO9 P2RX7 MARK4 MACF1	3.01e-03	1206	230	19	EFO_0004458
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	PTPRO ADGRL2	3.18e-03	11	230	2	EFO_0004471, EFO_0009131
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	ETV6 RB1CC1	3.18e-03	11	230	2	EFO_0007889, EFO_0009366
Disease	FEV/FEC ratio	STARD13 HIVEP2 CTTNBP2 BACH2 CIB4 CDH23 ETV6 NEB ARHGEF17 DENND5A AKAP6 COL15A1 PCDHGA5 EPB41L5 CRTC1 TUT1 DENND3 ZNF516 KIF13A	3.66e-03	1228	230	19	EFO_0004713
Disease	S-7-hydroxywarfarin to S-warfarin ratio measurement	STARD13 TOX BACH2 IQCA1	3.74e-03	81	230	4	EFO_0803334
Disease	mean reticulocyte volume	BACH2 ETV6 NEB CLCN6 ACSBG1 NYNRIN GNA15 PCDHGA5 RNPEPL1 RTTN TBL1XR1 E2F8 MARK4 MYB	4.22e-03	799	230	14	EFO_0010701
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	HIRA PRODH2	5.18e-03	14	230	2	DOID:0060413 (implicated_via_orthology)
Disease	Adenocarcinoma Of Esophagus	ARID1A CRTC1	5.18e-03	14	230	2	C0279628
Disease	Malignant neoplasm of liver	PTPRO DPP10 SIX3 DICER1 TNK2	5.21e-03	142	230	5	C0345904
Disease	Liver neoplasms	PTPRO DPP10 SIX3 DICER1 TNK2	5.21e-03	142	230	5	C0023903
Disease	respiratory system disease	PRR5L BACH2 EMSY GNA15 TBL1XR1	5.68e-03	145	230	5	EFO_0000684
Disease	age of onset of childhood onset asthma	BACH2 EMSY NFATC3 TBL1XR1	5.88e-03	92	230	4	OBA_2001015
Disease	platelet storage pool deficiency (implicated_via_orthology)	LYST HPS1	5.94e-03	15	230	2	DOID:2223 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	TSC1 TBL1XR1	5.94e-03	15	230	2	C0496930
Disease	Replication Error Phenotype	ARID1A MSH3	5.94e-03	15	230	2	C1721098
Disease	Microsatellite Instability	ARID1A MSH3	5.94e-03	15	230	2	C0920269
Disease	Benign neoplasm of bladder	TSC1 TBL1XR1	5.94e-03	15	230	2	C0154017
Disease	Carcinoma in situ of bladder	TSC1 TBL1XR1	5.94e-03	15	230	2	C0154091
Disease	head and neck squamous cell carcinoma (is_implicated_in)	TNFRSF10A PTPN13	5.94e-03	15	230	2	DOID:5520 (is_implicated_in)
Disease	Rhabdomyosarcoma	DICER1 SLC22A18	5.94e-03	15	230	2	C0035412
Disease	asthma	CYLD HIVEP2 PRR5L NFILZ BACH2 ETV6 EMSY GNA15 KYNU DPP6 COL15A1 TBL1XR1 SPRY4	6.34e-03	751	230	13	MONDO_0004979
Disease	breast cancer (is_implicated_in)	NCOA6 RB1CC1 ARID1A PTPN13 SLC22A18	6.54e-03	150	230	5	DOID:1612 (is_implicated_in)
Disease	developmental disorder of mental health (implicated_via_orthology)	GIGYF1 SRCAP PLXNB1	6.61e-03	49	230	3	DOID:0060037 (implicated_via_orthology)
Disease	platelet component distribution width	HIVEP2 SDCCAG8 RIPOR3 NYNRIN NR3C2 KYNU RNPEPL1 COBLL1 RTTN NXN MARK4 MACF1 MYB	6.62e-03	755	230	13	EFO_0007984
Disease	DiGeorge Syndrome	HIRA UFD1	6.76e-03	16	230	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	HIRA UFD1	6.76e-03	16	230	2	C0795907
Disease	behavioural inhibitory control measurement	STRA6 MROH2A	6.76e-03	16	230	2	EFO_0008467
Disease	Shprintzen syndrome	HIRA UFD1	6.76e-03	16	230	2	C0220704
Disease	Inhalant adrenergic use measurement	BACH2 EMSY TBL1XR1 SPRY4	6.83e-03	96	230	4	EFO_0009941
Disease	autism spectrum disorder (implicated_via_orthology)	TSC1 DSCAML1 NLGN4X NR3C2 NLGN4Y	6.91e-03	152	230	5	DOID:0060041 (implicated_via_orthology)
Disease	alopecia areata	EMSY PLEKHH2 STX17	7.00e-03	50	230	3	EFO_0004192
Disease	cholesteryl esters to total lipids in IDL percentage	ARID1A COBLL1 MACF1	7.00e-03	50	230	3	EFO_0022247
Disease	HbA1c measurement	NDOR1 TRAIP ITGB2 FAM186A CDT1 PLD1 PLEKHH2 COBLL1 SIX3 MACF1 NOSTRIN MYB	7.02e-03	675	230	12	EFO_0004541
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A CDH23 STRC	7.39e-03	51	230	3	cv:CN043650
Disease	S-adenosylhomocysteine measurement	CACNA1B CRTC1	7.62e-03	17	230	2	EFO_0010531

Protein segments in the cluster

Peptide	Gene	Start	Entry
RMISVNIFRTLPPSE	PPP2R5B	131	Q15173
PMVTSPREEQQLLAS	KCTD13	151	Q8WZ19
FQLLLAESMPPAESV	CHRNA10	281	Q9GZZ6
ILDTPEMPLEITRSF	C2orf42	446	Q9NWW7
EERAPPNSSLDQMVL	CCDC185	596	Q8N715
RPSINEIPERTMSVS	ERBIN	1146	Q96RT1
PVLRPMDLPTASSIN	BACH2	731	Q9BYV9
DKDIPARVTLMQLPT	EIF3B	486	P55884
LVDPMDRSVLHSQPI	APBB2	481	Q92870
RMEPSSLPQEIIANA	CACNA1E	1901	Q15878
TTPQLPEDMVLVSRI	CCDC7	641	Q96M83
MAADPTELRLGSLPV	ANKK1	1	Q8NFD2
MICSSLPERISPLQA	GJA10	271	Q969M2
NKLATLSVRAMPLPE	EFL1	746	Q7Z2Z2
SLSPAMVVPEDQLTR	CDT1	316	Q9H211
LADNLLEPTRVSMPT	ADGRL2	651	O95490
LEPTRVSMPTENIVL	ADGRL2	656	O95490
CSPEMQERLLPALQS	ALDH3B2	171	P48448
SANVPRSPVRELLEM	DICER1	1846	Q9UPY3
LQDIAMPELAPRNSS	DENND3	476	A2RUS2
MPELAPRNSSLRLTD	DENND3	481	A2RUS2
SMPRLAAETQPVTDA	CACNA1B	2001	Q00975
PSQRVESMEALPILS	CAMSAP1	1421	Q5T5Y3
ESMEALPILSRNPSR	CAMSAP1	1426	Q5T5Y3
QPAISVRLPDDMSAL	CDH23	3051	Q9H251
RDMLPSPEQTLSPLS	COBLL1	906	Q53SF7
RQVSIEPMPSLLDVR	IQCA1	531	Q86XH1
INDSLVPTMVIPRFT	DPP10	256	Q8N608
VPTNIPFDTRMLDLQ	ASPN	96	Q9BXN1
MDPPDLLSVELSTSR	TNK2	491	Q07912
LLEPPSLAEASLMQL	PRODH2	221	Q9UF12
PQESASPTLNRIDMA	NFILZ	171	A0A5F9ZHS7
DLATLPPTTAMAVLL	INTS8	131	Q75QN2
PVGTRLLMLTATDPD	PCDHGA5	256	Q9Y5G8
IPSIPQDLESREAMS	GOLGA8S	436	H3BPF8
ELPLNTIMLLPSRSE	KIAA1549	701	Q9HCM3
KTNRDIMSSENLPPI	LRRC9	1186	Q6ZRR7
MLPPSSSEPILVEQR	ARHGEF17	856	Q96PE2
EDMNLSLQSRPSSLP	ARID1A	626	O14497
PDLTLSFMNPRLLDD	AP3M2	216	P53677
VLSPDMPRTTNESLL	RB1CC1	241	Q8TDY2
SSPRQESTRVIQLMP	ETV6	256	P41212
MLTLLAEDRAVPSAP	FHIP1B	76	Q8N612
TRMSSLQPVELLLPS	MSH3	416	P20585
LPDAPEQRLRVMTTN	ELOA2	611	Q8IYF1
TDLSAIMPSQLRPVT	FIGN	711	Q5HY92
PTIFSTNPNLLLMER	FAM166C	71	A6NJV1
LFSVPPDLPMDTRNL	LRRC55	56	Q6ZSA7
VVMDRIRSFPLSSPI	MDN1	3756	Q9NU22
LDLSENRLESLPPQM	FLII	156	Q13045
SRALTPSPVMVLENI	NR3C2	731	P08235
TVMVPSLLRDVPLAD	MID1IP1	31	Q9NPA3
LARDMTLPPETNVIL	MAP4	446	P27816
DQNLLPTMSRSLSVP	GIGYF1	626	O75420
MDVQATTPLDPRVLD	NFS1	61	Q9Y697
LRLVSISNEPMDVPA	GREB1	101	Q4ZG55
LEELAMVTSLRPPVQ	RASGRP2	341	Q7LDG7
VAMRPSDLCPRVLST	NFKBID	166	Q8NI38
TMPVRLLRDSPAAQE	HSPB9	31	Q9BQS6
LVSMAPLTNEIRPVS	FAM91A1	501	Q658Y4
GLQEMRLPSPELELS	LTK	456	P29376
MPLQPSILREVSEEH	POLD2	101	P49005
LREAPDSLPEFTVQM	PLXNB1	1451	O43157
DLARALAEQLPPNMS	GGT7	271	Q9UJ14
PGPMLRVTSLDTEVL	SLC10A3	101	P09131
TPRSLPEDDTSMAIL	PDE2A	606	O00408
PLMVVATTSRAQDLP	PEX6	566	Q13608
SSPMPVTEALDRVLE	PDE8A	406	O60658
EEAEQLLQLMTSRPP	INTS2	406	Q9H0H0
LETLENLSSRLRMPP	MACF1	2031	O94854
TLLPNEIAIRPMDKT	KNL1	1166	Q8NG31
LQFLDTQAPMLTDPR	MED12	571	Q93074
TQAPMLTDPRSESER	MED12	576	Q93074
PVADAPNILTSSVLM	MYB	561	P10242
VMQPQRIFDSTLPSL	LRGUK	396	Q96M69
LLDMIPPRSISQSIS	GATAD2B	576	Q8WXI9
VPTAQDVLRSRMPTT	GNA15	176	P30679
LTANLRLPMASALPE	PARP4	1471	Q9UKK3
TQDPPATMELAVAVL	PELP1	141	Q8IZL8
ETSLAELRNQMAEPP	GOLGA2	436	Q08379
TRLFSTLDPELMLNP	GOLGA3	181	Q08378
MDPVTFIQTLPSDLR	HUWE1	3056	Q7Z6Z7
MQNCSTPLALPTRDL	KIF18B	706	Q86Y91
SESLEKMTLPNLPRL	PLCXD1	266	Q9NUJ7
ISMIRPLRPQETDLD	PLEKHH2	476	Q8IVE3
LSPREDPEMSTALSR	FAM131B	296	Q86XD5
DQLFMLQPREPDVSS	NDOR1	271	Q9UHB4
IISNPRDIQMAETSP	MORC2	216	Q9Y6X9
ATATMIQPELALIPS	GRIN3A	401	Q8TCU5
SNTSMLRLVKLEPAP	PTPRO	711	Q16827
LHTLLDPRNMLTTPE	PPP4R3C	441	Q6ZMV5
PITAVSRPLNEMVLT	PRR5L	256	Q6MZQ0
SRPLNEMVLTPLTEQ	PRR5L	261	Q6MZQ0
TRLMEPAVEPLTQAL	MCAT	271	Q8IVS2
SPAMREAPTSLSQLL	NCOA6	1481	Q14686
DPDSIRCDTRPQLLM	ITGB2	56	P05107
TLTLRRSPDDIPFMT	NLGN4Y	761	Q8NFZ3
RPAMDFTDLSRLPLA	P2RX7	431	Q99572
LEQIMAPLQPSTSRA	FAM189A2	381	Q15884
DVISNPSDLPRSLVM	ADAMTS3	1071	O15072
DLTLLNPRMIVDVTP	CLCN6	791	P51797
QLEMENSPLLSPRSN	EPB41L5	511	Q9HCM4
SQRMVLTVLPSEPTL	CD101	931	Q93033
LPSSPEREVQIVSTM	IGSF3	61	O75054
LDPSPLRDTVASALM	KLHL22	261	Q53GT1
ICLERQVPLASPSSM	DOC2A	211	Q14183
AEMELTAPSLIQPLG	E2F8	481	A0AVK6
PLSPITQAVAMDALS	CRTC1	331	Q6UUV9
PVLSATINNLRMPVS	CTTNBP2	1566	Q8WZ74
PREESMLPLLTQDSN	DBX2	166	Q6ZNG2
LIDMSDIRPGTNPVS	DSCAML1	1716	Q8TD84
SRLMDPPSNEAVLLS	DHX36	656	Q9H2U1
ERFALVLSSMNLPPD	FMNL3	36	Q8IVF7
EMKPSEARVPQLSSL	IFNK	146	Q9P0W0
PSMLDSRETPQESRQ	ACSBG1	16	Q96GR2
DPEALAQLMLSIPLT	APPL2	621	Q8NEU8
TLESLPEQLPVADMR	ELMO3	586	Q96BJ8
SDASSLMPPLRISLI	DENND5A	851	Q6IQ26
PDAMALENSREIIPR	LYST	216	Q99698
TDPILLTSMCQPREQ	FBXO40	676	Q9UH90
MSARTPLPTVNERDT	MARK1	1	Q9P0L2
DPANITLEPMEIRTF	MAN2B1	986	O00754
MSSARTPLPTLNERD	MARK2	1	Q7KZI7
SSRPPEALMAALRQA	MARK4	666	Q96L34
SIPVMVVTLDPTRDQ	TMEM259	231	Q4ZIN3
RLIPTLVSIMQAPAD	IPO9	646	Q96P70
LPPSREEMTKNQVSL	IGHG3	281	P01860
ESITRAVASLPPEQM	CSTF2T	126	Q9H0L4
LESKPRQPTIDLSQM	EMSY	791	Q7Z589
DSTIMRREPQNILSP	FAM186A	21	A6NE01
RLMPVSLSVQSPAAL	HIRA	651	P54198
DTMQVELPPLEINSR	CYLD	221	Q9NQC7
AAINDSRVPIMELPT	DPP6	316	P42658
VRASPAEMEELLLPT	GRIP2	921	Q9C0E4
EAPTPALKRTLDSMN	GYS1	81	P13807
SPSAPLALVLSQLMD	HPS1	386	Q92902
LAPLTATMAPERAVT	COL15A1	486	P39059
TLTLRRSPDDIPLMT	NLGN4X	761	Q8N0W4
PSLSAGRAEPVLMID	PKD1L1	1116	Q8TDX9
VTEPTRITLAPSNMD	CNTN3	496	Q9P232
TSPVRLAARQEDAPM	EPB41L3	761	Q9Y2J2
SLPLENTIPFRNVMT	HELB	196	Q8NG08
PSEMITAQSALPERE	HS3ST4	146	Q9Y661
MVVDLTDPNRPRFTL	RILPL2	121	Q969X0
SPLLPLGQDMQERAS	CPHXL	381	A0A1W2PPM1
PESTAMRLLSGLEVP	R3HDML	36	Q9H3Y0
IPEMPRLFLTSDLDS	PIDD1	311	Q9HB75
MTIEPFISLDLPRSI	PTPN13	546	Q12923
LMAPNSQLPFRLEVT	NYNRIN	1151	Q9P2P1
PETTLVSMSPRALAE	FAM181A	241	Q8N9Y4
LSSMLAELEQRPQPS	NOSTRIN	366	Q8IVI9
ETILTSLLRQPLPME	MROH2A	1156	A6NES4
LLSIPRLPSMVEASD	MSH5	446	O43196
IALEARPLLSQESMP	KIF13A	1481	Q9H1H9
PSVPMKEEVLNLLSR	RTTN	56	Q86VV8
MESLSELQNPLLPRS	SYNDIG1L	1	A6NDD5
TMEVETLIRSASPPL	SZT2	2726	Q5T011
IMADLNLSLPSIPEV	RAB11FIP1	951	Q6WKZ4
RLLDGSPLPQEVVMS	RNPEPL1	571	Q9HAU8
VMLDAPLVSSSLPQP	STARD13	221	Q9Y3M8
LTPNSVMVQPLLDSR	SPRY4	11	Q9C004
RLQTTDNLLPMSPEE	STAT1	716	P42224
LPMQAVRCSLSDIPD	TDRD6	1091	O60522
PLRPANASLEEMASL	TATDN2	116	Q93075
SVMEQNPLRSEPALV	PTAR1	256	Q7Z6K3
REELMTTPILQPTEA	SMAGP	11	Q0VAQ4
EMTLRDLPSPGLELS	LRRC27	191	Q9C0I9
TNLPEAAPLLTILDM	NXN	386	Q6DKJ4
IPLSSVMIIDNRDFP	PIGL	101	Q9Y2B2
PSLPRSSENMIREEQ	PLD1	161	Q13393
EEVDRLRTQLPSMPQ	SDCCAG8	696	Q86SQ7
LLANSPLMEDAPQRL	SGSM3	61	Q96HU1
RAPPEELSMFQLPTL	SIX3	71	O95343
LPLHSSQDRLLPMTV	MAPKAP1	181	Q9BPZ7
MDSTVPSALELPQRL	CCT8L1P	1	A6NM43
MDSTVPSALELPQRL	CCT8L2	1	Q96SF2
DMLTAADRLPTQAPL	SPATA31E1	1136	Q6ZUB1
DMTPLNLSSRAEPVR	WIZ	1211	O95785
SSMSPPIAEQIIRSL	SPTLC3	401	Q9NUV7
LSPDMQARLPSGEVV	SRCAP	1171	Q6ZRS2
PMEERISNLRLNPTL	ODF3L1	106	Q8IXM7
TTALQDPMVSPRLDV	PLA2G3	326	Q9NZ20
ITRSSMLSLIPQPQD	SIGLEC12	321	Q96PQ1
QMAASREVPRPLSTL	SGCA	346	Q16586
VSDLMRFPPSLLAND	STRC	811	Q7RTU9
VPASSPVMEQVLLSL	NCKIPSD	346	Q9NZQ3
RPIESLSLIDAVMPD	TBL1XR1	76	Q9BZK7
AQMVITDLSAPEERP	SLC22A18	136	Q96BI1
MRTISFDIPPQEILT	STOM	96	P27105
QMDLSLLPPRAATLD	STRA6	546	Q9BX79
VTLSPLRSQDLDPMA	AKAP6	6	Q13023
LTLEPEIMPAATDNR	ACY1	336	Q03154
TMDQVSSLPALRVNP	CIB4	51	A0PJX0
PVDPSNRSNSMLELA	CGN	146	Q9P2M7
SVQTAAPSPLRLMDL	CHPF	586	Q8IZ52
DTISILPDDPRQMTL	CHURC1	96	Q8WUH1
LEEPSMRQSSPAETV	C10orf67	536	Q8IYJ2
AESLDAEVMPQVRSP	PNMA5	131	Q96PV4
LSRQSATEIPLPMLP	SEPTIN1	316	Q8WYJ6
GRPIESLSLIDAVMP	TBL1X	126	O60907
EPLTLASLLEDMPTR	TSGA13	236	Q96PP4
NTTMVLDVLPDARPV	URGCP	131	Q8TCY9
LPSCLPLTDNTRMLA	UNC45B	341	Q8IWX7
LAPDLMPLDLSARST	ZNF516	726	Q92618
PSTSPMEVLDRLIQQ	TSC1	641	Q92574
PDLSVISMLEQRRDP	ZNF880	51	Q6PDB4
SMLQEDLLRLPSFPR	UNC80	2121	Q8N2C7
MPREDATQLEVTLPS	VSIG1	291	Q86XK7
EGSPTQLPILADMLL	PIK3R5	646	Q8WYR1
PSLRSQSQELPEMDS	RIPOR3	391	Q96MK2
RASVDVDLLAPRSPM	PLPPR3	351	Q6T4P5
MEISAPVLISSSDPR	SH3RF3	401	Q8TEJ3
VSPADRMLTVTPLQD	TUT1	836	Q9H6E5
NDEETLLQPPLTRSM	STX17	121	P56962
DLMEVSSPSPAQRLR	SPOCD1	506	Q6ZMY3
MQETPNRDLVLEPSL	SPANXN5	26	Q5MJ07
NRQTLTESMLEPVPE	UBE4B	1271	O95155
VPATMNARTELDSPR	TNR	676	Q92752
RMEISAELPQTPQRL	UBR1	11	Q8IWV7
TQLAERIPTSPCLMT	MYCBPAP	161	Q8TBZ2
LEIPLLPENNMSASI	NFATC3	521	Q12968
MEDTLQAPTPLQIER	PLCG1	141	P19174
FEDTMVIDLPPSRNR	STAG1	1216	Q8WVM7
LLVPANGADPTETLM	TNFRSF10A	351	O00220
SMLRPLELSLPSQTS	UACA	421	Q9BZF9
IIMPPSALDQLSRLN	UFD1	46	Q92890
IMATNRPDTLDPALL	PSMC6	276	P62333
VSDLMRFPPSLLAND	STRCP1	811	A6NGW2
IASMLSKNPEDRPSL	PLK2	311	Q9NYY3
LLAAAMPRSAPNDIL	WNT10A	31	Q9GZT5
MDSQESLRNPLIQPT	HIVEP2	1161	P31629
TAIPANLPETMTEIR	SLIT1	301	O75093
MELSSTRLERPLEPQ	TRIM66	641	O15016
SPSILAMLETLQNAP	UBR2	966	Q8IWV8
LSNSISVMPDIRNPE	TOX	131	O94900
VLMSQTEADLALRPP	WNK4	11	Q96J92
DPDLSRCPEMVLQLS	SLFN5	336	Q08AF3
MDSPSLRELQQPLLE	TMEM91	1	Q6ZNR0
LTMLQETLNLPPVAS	TRAIP	271	Q9BWF2
NRLETPMELRLDSPS	VPS13D	3056	Q5THJ4
RTTRTAPLDMPLAEA	GARIN5B	166	Q8N5Q1
PLLSPSLSHRERDQM	KIAA2013	376	Q8IYS2
MEPSSLELPADTVQR	KYNU	1	Q16719
VNPPDLMSCLTSRTL	MYO7A	361	Q13402
HVMPDTPDILLSRVN	NEB	1761	P20929